Cargando...
Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present)
INTRODUCTION: Anticoagulation without bleeding is an ideal goal in treating thrombosis, however, this goal has not been achieved. All current anticoagulants are associated with significant bleeding which limits their safe use. Genetic and pharmacological findings indicate that factor XIa is a key pl...
Gardado en:
| Publicado en: | Expert Opin Ther Pat |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515655/ https://ncbi.nlm.nih.gov/pubmed/31847619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543776.2020.1705783 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|